Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients ...Middle East

News by : (PR Newswire) -

EATONTOWN, N.J., Feb. 14, 2025 /PRNewswire/ -- Avertix Medical, Inc. ("Avertix" or the "Company"), the developer of The Guardian® system - the world's first real-time, continuous heart attack detection and patient alerting system today announced compelling new data confirming the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients )

Also on site :

Most Viewed News
جديد الاخبار